We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomised trial demonstrates symptom improvements in Crohn's disease with infliximab therapy, suggesting efficacy.
ClinicalTrials. gov identifier, NCT03945019 (08 May 2019).
No takes yet. Share an insight, caveat, or question.
Schreiber et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: